(Q51562466)

English

Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion.

scientific article published in February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretion. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

author name string

Hunter SJ

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Shaw JA

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Wood PJ

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Atkinson AB

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Bevan JS

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

50

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

245-251

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Epidemiology of acromegaly in the Newcastle region.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Use of Insulin-Like Growth Factor-Binding Protein 3 for the Evaluation of Growth Disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Sandostatin LAR in acromegalic patients: a dose-range study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

A long-term dose-response study of somatostatin analogue (SMS 201-995, octreotide) in resistant acromegaly.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1999.00668.X

21 January 2018

Identifiers

10.1046/J.1365-2265.1999.00668.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10396369

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51562466&oldid=931976421"